AbstractObjectiveTo determine the effect of introducing prospective monitoring of outcomes using control charts and regular feedback on indicators […]
This interview was conducted on 28 October and has been edited for length and clarityHow are you, Chris?I’m […]
I was recently part of a webcast panel event discussing the freedom of health professionals to speak out […]
Drug will be launched in the UK first
Deucravacitinib demonstrated superiority to placebo and Otezla in phase III
Trial will evaluate Sativex (nabiximols) for multiple sclerosis spasticity
British drugmaker confirmed review on Sunday
Updated Date: Tue, 27 Oct 2020 00:00:00 EDT
Updated Date: Tue, 27 Oct 2020 00:00:00 EDT
Amgen’s Otezla faces a hit from Bristol’s would-be rival, but safety data will tell the full story esagonowsky […]